NOAEL Studies
Cosmetic Ingredient
Malonic Acid NOAEL Studies
INCI: MALONIC ACID
CAS: 141-82-2
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
CIR Safety Assessment 17 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| CIR Safety Assessment | NOAEL | =1 | % | rat | oral | 2-year | inhalation toxicity | 2; 20; 0, p.16 |
| CIR Safety Assessment | NOAEL | =2 | % | rat | oral | 90 days | repeated dose toxicity | 1; 2; 4, p.17 |
| CIR Safety Assessment | NOAEL | =3 | % | rat | oral | 180 days | oral toxicity | 30; 10; 3, p.17 |
| CIR Safety Assessment | NOAEL | =170 | mg/kg bw/d | - | oral | 10 weeks | developmental toxicity | 28, 170; 10; 92, p.55 |
| CIR Safety Assessment | NOAEL | =200 | mg/kg bw | rat | - | 4 weeks | NOAEL study | 200; 4, p.41 |
| CIR Safety Assessment | NOAEL | =250 | mg/kg bw | rat | oral | - | developmental toxicity | 4; 205; 6, p.21 |
| CIR Safety Assessment | NOAEL | =263 | mg/kg bw | rat | oral | - | developmental toxicity | 6; 15; 38, p.21 |
| CIR Safety Assessment | NOAEL | =288 | mg/kg bw | rat | oral | - | developmental toxicity | 6; 15; 38, p.21 |
| CIR Safety Assessment | NOAEL | =300 | mg/kg bw | rat | - | - | developmental toxicity | 100; 300; 5, p.53 |
| CIR Safety Assessment | NOAEL | >435 | mg/kg bw | rat | oral | 4 weeks | oral toxicity | 5; 0; 20, p.14 |
| CIR Safety Assessment | NOAEL | =500 | mg/kg bw/d | rat | oral | 13 weeks | repeated dose toxicity | 10; 0, 50, 150; 500, p.45 |
| CIR Safety Assessment | NOAEL | =610 | mg/kg bw | rat | oral | 90-day | repeated dose toxicity | 2; 90; 10, p.41 |
| CIR Safety Assessment | NOAEL | =1000 | mg/kg bw | rat | - | - | developmental toxicity | 0; 54; 35, p.21 |
| CIR Safety Assessment | NOAEL | =2000 | mg/kg bw/d | rat | - | 5 days | developmental toxicity | 0; 3; 16, p.54 |
| CIR Safety Assessment | NOAEL | =3333 | mg/kg bw | rat | oral | 19 weeks | oral toxicity | 8; 10; 0, 420, 840, p.16 |
| CIR Safety Assessment | NOAEL | <4000 | mg/kg | rat | - | - | NOAEL study | 9; 1; 92, p.42 |
| CIR Safety Assessment | NOAEL | >8000 | mg/kg | rat | dermal | - | NOAEL study | 111; 9; 121, p.43 |
NTP ICE acute inhalation 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP ICE acute inhalation | LC50 | >8.9 | mg/L | - | Inhalation | Duration=1 hr | In Vivo; AcuteInhalNICEATM; Rat Acute Inhalation Toxicity | sheet=Data; excel_row=3900; Record_ID=acute_inhalation_3082; Data_Type=In Vivo; Internal_Data_Source=AcuteInhalNICEATM; Mixture=Chemical; DTXSID=DTXSID7021659; Assay=Rat Acute Inhalation Toxicity; Endpoint=LC50; Response_Modifier=>; Response=8.9; Response_Unit=mg/L; Reference=ChemIDplus; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7021659; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7021659 |
ToxValDB GESTIS DNEL 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB GESTIS DNEL | DNEL systemic | =4.2 | mg/m3 | Human | inhalation | - | Toxicity Value | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/6543dd69e4b045b9ff7cd87e; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://www.dguv.de/ifa/gestis/gestis-dnel-liste/index-2.jsp; STUDY_GROUP=GESTIS DNEL:15633154:-:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_70eff6f8211171fec29ad6d3584a51cc |
Regulatory source 18 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 200 | mg/kg bw | rat | - | 4 weeks | - | p.41 |
| Regulatory source | - | <4000 | mg/kg | rat | - | - | - | p.42 |
| Regulatory source | - | >8000 | mg/kg | rat | dermal | - | - | p.43 |
| Regulatory source | developmental toxicity | 170 | mg/kg bw/d | - | oral | 10 weeks | developmental toxicity | p.55 |
| Regulatory source | developmental toxicity | 250 | mg/kg bw | rat | oral | - | developmental toxicity | p.21 |
| Regulatory source | developmental toxicity | 263 | mg/kg bw | rat | oral | - | developmental toxicity | p.21 |
| Regulatory source | developmental toxicity | 288 | mg/kg bw | rat | oral | - | developmental toxicity | p.21 |
| Regulatory source | developmental toxicity | 300 | mg/kg bw | rat | - | - | developmental toxicity | p.53 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw | rat | - | - | developmental toxicity | p.21 |
| Regulatory source | developmental toxicity | 2000 | mg/kg bw/d | rat | - | 5 days | developmental toxicity | p.54 |
| Regulatory source | inhalation toxicity | 1 | % | rat | oral | 2-year | inhalation toxicity | p.16 |
| Regulatory source | oral toxicity | 3 | % | rat | oral | 180 days | oral toxicity | p.17 |
| Regulatory source | oral toxicity | >435 | mg/kg bw | rat | oral | 4 weeks | oral toxicity | p.14 |
| Regulatory source | oral toxicity | 3333 | mg/kg bw | rat | oral | 19 weeks | oral toxicity | p.16 |
| Regulatory source | repeated dose toxicity | 1 | % | rat | oral | 13-week | repeated dose toxicity | p.45 |
| Regulatory source | repeated dose toxicity | 2 | % | rat | oral | 90 days | repeated dose toxicity | p.17 |
| Regulatory source | repeated dose toxicity | 500 | mg/kg bw/d | rat | oral | 13 weeks | repeated dose toxicity | p.45 |
| Regulatory source | repeated dose toxicity | 610 | mg/kg bw | rat | oral | 90-day | repeated dose toxicity | p.41 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 9KX7ZMG0MK | UNII | - | - | - | chemical | - |